Raltitrexed-eloxatin (TOM OX) salvage chemotherapy (CHT) in gemcitabine (GEM) resistant metastatic pancreatic cancer (PC): a phase II trial
Abstract
Publication Date:
2005
Iris type:
4.2 Abstract in Atti di convegno
List of contributors:
Reni, M; Bonetto, E; Pasetto, L; Aprile, G; Cordio, S; Passoni, P; Dell'Oro, S; Luppi, G; Milandri, C; Fugazza, C; Raffaele, Sh
Book title:
proceedings of the ASCO
Published in: